These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31540495)

  • 1. Interleukin4Rα (IL4Rα) and IL13Rα1 Are Associated with the Progress of Renal Cell Carcinoma through Janus Kinase 2 (JAK2)/Forkhead Box O3 (FOXO3) Pathways.
    Kang MA; Lee J; Ha SH; Lee CM; Kim KM; Jang KY; Park SH
    Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31540495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL13Rα2 Is Involved in the Progress of Renal Cell Carcinoma through the JAK2/FOXO3 Pathway.
    Kang MA; Lee J; Lee CM; Park HS; Jang KY; Park SH
    J Pers Med; 2021 Apr; 11(4):. PubMed ID: 33917914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL4Rα and IL13Rα1 Are Involved in the Development of Human Gallbladder Cancer.
    Ahn SW; Lee CM; Kang MA; Hussein UK; Park HS; Ahn AR; Yu HC; Yang JD; Yang YH; Park K; Lee J; Jang KY; Park SH
    J Pers Med; 2022 Feb; 12(2):. PubMed ID: 35207737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of IL4Rα and IL13Rα1 are associated with poor prognosis of soft-tissue sarcoma of the extremities, superficial trunk, and retroperitoneum.
    Kim KM; Hussein UK; Park SH; Moon YJ; Zhang Z; Ahmed AG; Ahn AR; Park HS; Kim JR; Jang KY
    Diagn Pathol; 2021 Jan; 16(1):2. PubMed ID: 33419470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetylshikonin, A Novel CYP2J2 Inhibitor, Induces Apoptosis in RCC Cells via FOXO3 Activation and ROS Elevation.
    Lim HM; Lee J; Yu SH; Nam MJ; Cha HS; Park K; Yang YH; Jang KY; Park SH
    Oxid Med Cell Longev; 2022; 2022():9139338. PubMed ID: 35308176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The IGF-I/JAK2-STAT3/miR-21 signaling pathway may be associated with human renal cell carcinoma cell growth.
    Su Y; Zhao A; Cheng G; Xu J; Ji E; Sun W
    Cancer Biomark; 2017 Jul; 19(3):289-296. PubMed ID: 28453463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of interleukin 13 receptor in glioma and renal cell carcinoma: IL13Ralpha2 as a decoy receptor for IL13.
    Bernard J; Treton D; Vermot-Desroches C; Boden C; Horellou P; Angevin E; Galanaud P; Wijdenes J; Richard Y
    Lab Invest; 2001 Sep; 81(9):1223-31. PubMed ID: 11555670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-coding RNA 886 promotes renal cell carcinoma growth and metastasis through the Janus kinase 2/signal transducer and activator of transcription 3 signaling pathway.
    Lei J; Xiao JH; Zhang SH; Liu ZQ; Huang K; Luo ZP; Xiao XL; Hong ZD
    Mol Med Rep; 2017 Oct; 16(4):4273-4278. PubMed ID: 28765891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Expression Patterns of FAM83H and PANX2 Are Associated With Shorter Survival of Clear Cell Renal Cell Carcinoma Patients.
    Kim KM; Hussein UK; Bae JS; Park SH; Kwon KS; Ha SH; Park HS; Lee H; Chung MJ; Moon WS; Kang MJ; Jang KY
    Front Oncol; 2019; 9():14. PubMed ID: 30723706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of FOXO3 is associated with poor prognosis in patients with hepatocellular carcinoma.
    Song SS; Ying JF; Zhang YN; Pan HY; He XL; Hu ZM; Wang HJ; Dou XB; Mou XZ
    Oncol Lett; 2020 Apr; 19(4):3181-3188. PubMed ID: 32256814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A positive feed-forward loop between LncRNA-URRCC and EGFL7/P-AKT/FOXO3 signaling promotes proliferation and metastasis of clear cell renal cell carcinoma.
    Zhai W; Zhu R; Ma J; Gong D; Zhang H; Zhang J; Chen Y; Huang Y; Zheng J; Xue W
    Mol Cancer; 2019 Apr; 18(1):81. PubMed ID: 30953521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tumour suppressor FOXO3 is a key regulator of mantle cell lymphoma proliferation and survival.
    Obrador-Hevia A; Serra-Sitjar M; Rodríguez J; Villalonga P; Fernández de Mattos S
    Br J Haematol; 2012 Feb; 156(3):334-45. PubMed ID: 22107151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miRNA-133b and miRNA-135a induce apoptosis via the JAK2/STAT3 signaling pathway in human renal carcinoma cells.
    Zhou W; Bi X; Gao G; Sun L
    Biomed Pharmacother; 2016 Dec; 84():722-729. PubMed ID: 27710896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-suppressive activity of 1,25-dihydroxyvitamin D3 against kidney cancer cells via up-regulation of FOXO3.
    Lee J; Park SH
    Biosci Biotechnol Biochem; 2016 Oct; 80(10):1947-53. PubMed ID: 27181027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitoxantrone induces apoptosis in osteosarcoma cells through regulation of the Akt/FOXO3 pathway.
    Park SH; Lee J; Kang MA; Jang KY; Kim JR
    Oncol Lett; 2018 Jun; 15(6):9687-9696. PubMed ID: 29928344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Houttuynia cordata Thunb Promotes Activation of HIF-1A-FOXO3 and MEF2A Pathways to Induce Apoptosis in Human HepG2 Hepatocellular Carcinoma Cells.
    Kim JM; Hwang IH; Jang IS; Kim M; Bang IS; Park SJ; Chung YJ; Joo JC; Lee MG
    Integr Cancer Ther; 2017 Sep; 16(3):360-372. PubMed ID: 27698266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of Forkhead Box O3 Facilitates Inflammatory Colon Cancer: Transcriptome Profiling of the Immune Landscape and Novel Targets.
    Penrose HM; Cable C; Heller S; Ungerleider N; Nakhoul H; Baddoo M; Hartono AB; Lee SB; Burow ME; Flemington EF; Crawford SE; Savkovic SD
    Cell Mol Gastroenterol Hepatol; 2019; 7(2):391-408. PubMed ID: 30718226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blocking Interleukin-4 Receptor α Using Polyethylene Glycol Functionalized Superparamagnetic Iron Oxide Nanocarriers to Inhibit Breast Cancer Cell Proliferation.
    Shaik AP; Shaik AS; Majwal AA; Faraj AA
    Cancer Res Treat; 2017 Apr; 49(2):322-329. PubMed ID: 27456946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GSK-3 directly regulates phospho-4EBP1 in renal cell carcinoma cell-line: an intrinsic subcellular mechanism for resistance to mTORC1 inhibition.
    Ito H; Ichiyanagi O; Naito S; Bilim VN; Tomita Y; Kato T; Nagaoka A; Tsuchiya N
    BMC Cancer; 2016 Jul; 16():393. PubMed ID: 27387559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.